Pacira | PCRX - صافي الدخل





صافي الدخل تغيير تاريخ
Assertio Holdings USD -2.92M 753K 2024-09
Astellas Pharma JPY 43.52B 56.86B 2026-03
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cara Therapeutics USD -5.53M 621K 2025-09
Coherus Biosciences USD -37.64M 2.11M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
J&J USD 5.24B 119M 2026-03
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
Nektar Therapeutics USD -36.08M 978K 2025-12
Novo Nordisk DKK 26.89B 388M 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12
Xoma USD -17.24M 33.23M 2024-09
Zoetis USD 603M 118M 2025-12